CB6513745 

CB6513745 is a MelF flavin-dependent oxidoreductase inhibitor with a K_i of 18 μM against Mycobacterium marinum MelF. CB6513745 inhibits the activity of MelF flavin-dependent oxidoreductase via hydrophobic interactions with the binding pocket of the protein. CB6513745 is applicable to research related to tuberculosis^[1].

CB6513745 noncompetitively inhibits the flavin oxidoreductase activity of purified Mycobacterium marinum MelF protein with a K_i of 18 μM, without causing protein denaturation or aggregation^[1].
CB6513745 exhibits bactericidal activity against Mycobacterium marinum strain M with an MIC of 19.39 μM and MBC of 38.77 μM, and against Mycobacterium tuberculosis H37Rv with an MIC of 38.77 μM and MBC of 38.77 μM; it also acts synergistically with INH against M. marinum^[1].
CB6513745 (19.39-96.95 μM; 20 h) is non-cytotoxic to HeLa cells at concentrations up to 5X its MIC against Mycobacterium marinum^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

322.41

C₂₀H₂₂N₂O₂

380449-90-1

OCC1=CN(N=C1C=2C=CC(OCC(C)C)=CC2)C=3C=CC=CC3

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Dharra R, et al. Rational design of drug-like compounds targeting Mycobacterium marinum MelF protein. PLoS One. 2017;12(9):e0183060. Published 2017 Sep 5.  [Content Brief]